Classification of chronic hepatitis: Diagnosis, grading and staging

Di Bisceglie A et al. Long-erm clinical and histopathological follow-up of chronic posttransfusion hepatitis 14: 969-974 405 Tsubota A et al. Factors predictive of response to interferon alpha therapy in HCV infection 19: 1088-94 393 Marcellin P et al. Recombinant human alpha-interferon in patients with chronic nonA-nonB hepatitis. A multicenter randomized controlled trial from France 13: 393-397 354

[1]  G. Klöppel,et al.  SEROLOGICAL CLASSIFICATION OF CHRONIC CHOLESTATIC LIVER DISEASE BY THE USE OF TWO DIFFERENT TYPES OF ANTIMITOCHONDRIAL ANTIBODIES , 1980, The Lancet.

[2]  I. Mackenzie,et al.  CONVULSIONS AND PROSTAGLANDIN-INDUCED ABORTION , 1973 .

[3]  R. D. de Man,et al.  Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. , 1992, Gastroenterology.

[4]  J. Ludwig,et al.  The nomenclature of chronic active hepatitis: an obituary. , 1993, Gastroenterology.

[5]  Eugene R. Schiff,et al.  Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa , 1989 .

[6]  P. Scheuer,et al.  Classification of chronic viral hepatitis: a need for reassessment. , 1991, Journal of hepatology.

[7]  J. Boyer,et al.  Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). , 1970, The New England journal of medicine.

[8]  S. Sherlock,et al.  Diseases of the liver and biliary tract : standardization of nomenclature, diagnostic criteria, and diagnostic methodology , 1976 .

[9]  J. Hoofnagle,et al.  Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. , 1993, Gastroenterology.

[10]  E. Schiff,et al.  Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis , 1992, Hepatology.

[11]  M. Rizzetto,et al.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. , 1977, Gut.

[12]  M. Manns,et al.  M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: Epitopes or epiphenomena? , 1992, Hepatology.

[13]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[14]  R. Klein,et al.  Anti-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space. , 1991, Clinical and experimental immunology.

[15]  J. Davison,et al.  Letter: Ultrasonic cephalometry. , 1973, Lancet.

[16]  E. Schiff,et al.  A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B , 1990 .

[17]  H. Popper.  Changing Concepts of the Evolution of Chronic Hepatitis and the Role of Piecemeal Necrosis , 2007 .

[18]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[19]  P. Johnson,et al.  Meeting report: International autoimmune hepatitis group , 1993, Hepatology.

[20]  F. Alvarez,et al.  Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitis , 1987, Hepatology.

[21]  L. Sobin,et al.  The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. , 1978, Journal of clinical pathology.

[22]  A. Dhillon,et al.  Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis , 1993, Hepatology.

[23]  H. Thomas,et al.  MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION , 1989, The Lancet.

[24]  K. Sullivan,et al.  LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. , 1991, The Journal of clinical investigation.

[25]  H. Popper.  Pathologic aspects of cirrhosis. A review. , 1977, The American journal of pathology.

[26]  P. Beaune,et al.  Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis. , 1990, The Journal of clinical investigation.

[27]  D. Vergani,et al.  Type II autoimmune hepatitis. What is the role of the hepatitis C virus? , 1993, Gastroenterology.

[28]  M. Manns,et al.  CHARACTERISATION OF A NEW SUBGROUP OF AUTOIMMUNE CHRONIC ACTIVE HEPATITIS BY AUTOANTIBODIES AGAINST A SOLUBLE LIVER ANTIGEN , 1987, The Lancet.

[29]  M. Manns,et al.  Anti-GOR and hepatitis C virus in autoimmune liver diseases , 1992, The Lancet.

[30]  D. Valla,et al.  Liver/kidney microsome antibody type 1 and hepatitis C virus infection , 1992, Hepatology.

[31]  A. Czaja,et al.  The nature and prognosis of severe cryptogenic chronic active hepatitis. , 1993, Gastroenterology.

[32]  S. Sherlock,et al.  The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis , 1986, Hepatology.

[33]  Brunetto.  Identification of HBV variants which cannot produce pre-core derived HBeAg and may be responsible for severe hepatitis , 1989 .

[34]  J. de Groote,et al.  A classification of chronic hepatitis. , 1968, Lancet.

[35]  K. Ishak,et al.  Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis , 1991, Hepatology.

[36]  P. Beaune,et al.  Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Iversen Ll.  Neurotransmitters and CNS disease. Introduction. , 1982 .

[38]  M. Lenzi,et al.  Type 2 autoimmune hepatitis and hepatitis C virus infection , 1990, The Lancet.

[39]  H. Popper,et al.  The vocabulary of chronic hepatitis. , 1971, The New England journal of medicine.

[40]  S. Yeaman,et al.  M4 and M9 autoantigens in primary biliary cirrhosis--a negative study. , 1993, Journal of hepatology.